Searchable abstracts of presentations at key conferences in endocrinology

ea0044p115 | Diabetes and Cardiovascular | SFEBES2016

Prevalence of dyslipidaemia in type 2 DM patients attending Obafemi Awolowo University Teaching Hospital Complex Ile Ife South West Nigeria

Enikuomehin Adenike , Mohammad Fakhraddeen , Soyoye David , Kolawole Babatunde , Ikem Rosemary , Adebayo Joseph

Many studies and treatment guidelines have emphasized that the treatment of DM extends beyond glycaemic control, but include lowering lipids, and blood pressure in people living with DM. According to The Task Force on Diabetes and Cardiovascular Disease of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD), dyslipidaemia is strongly related to increased CVD risk. This study determined the prevalence of dyslipidaemia in Typ...